AVORO CAPITAL ADVISORS
Avoro Capital Advisors is a global life sciences investment firm with a focus on supporting emerging biotechnology companies. Formerly known as venBio Select Advisor, ITwas established in 2010 and is headquartered in New York, United States.
AVORO CAPITAL ADVISORS
Social Links:
Industry:
Biopharma Biotechnology Financial Services Therapeutics
Founded:
2010-01-01
Status:
Active
Contact:
212.937.4970
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-19 | Kymera Therapeutics | Avoro Capital Advisors investment in Post-IPO Equity - Kymera Therapeutics | 150 M USD |
| 2021-08-11 | Tango Therapeutics | Avoro Capital Advisors investment in Post-IPO Equity - Tango Therapeutics | 186 M USD |
| 2021-05-11 | Nuvalent | Avoro Capital Advisors investment in Series B - Nuvalent | 135 M USD |
| 2021-03-31 | Scribe Therapeutics | Avoro Capital Advisors investment in Series B - Scribe Therapeutics | 100 M USD |
| 2021-03-12 | Monte Rosa Therapeutics | Avoro Capital Advisors investment in Series C - Monte Rosa Therapeutics | 95 M USD |
| 2021-02-24 | Vividion Therapeutics | Avoro Capital Advisors investment in Series C - Vividion Therapeutics | 135 M USD |
| 2021-01-27 | Design Therapeutics | Avoro Capital Advisors investment in Series B - Design Therapeutics | 125 M USD |
| 2021-01-13 | IO Biotech | Avoro Capital Advisors investment in Series B - IO Biotech | 127 M EUR |
| 2020-10-01 | Olema Oncology | Avoro Capital Advisors investment in Series C - Olema Oncology | 85 M USD |
| 2020-08-03 | PMV Pharmaceuticals | Avoro Capital Advisors investment in Series D - PMV Pharmaceuticals | 70 M USD |